IP Library Granted Patent US 9,376,478
Granted Patent B1
US 9,376,478 · App. 08/463,757 · Granted Jun 28, 2016

DNA and recombinant plasmid

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,376,478
App. No.
08/463,757
Granted
Jun 28, 2016
Kind
B1
Abstract

Disclosed is a recombinant plasmid having a gene which encompasses at least the entire coding region of human fibroblast interferon messenger RNA and a method for preparing such plasmid.

Claims (41)

1. A human fibroblast β 1 interferon polypeptide produced by the process comprising: expressing an expression plasmid in a host cell, said plasmid comprising a DNA sequence coding for human fibroblast β 1 interferon, whereby expression of human fibroblast β 1 interferon by a host is enabled, and recovering said interferon.

2. Recombinant human fibroblast β 1 interferon.

3. Recombinant human fibroblast β 1 interferon having the amino acid sequence:

Met Ser Tyr Asn Leu Leu Gly Phe Leu Gln Arg Ser Ser Asn Phe Gln Cys Gln Lys Leu Leu Trp Gln Leu Asn Gly Arg Leu Glu Tyr Cys Leu Lys Asp Arg Met Asn Phe Asp Ile Pro Glu Glu Ile Lys Gln Leu Gln Gln Phe Gln Lys Glu Asp Ala Ala Leu Thr Ile Tyr Glu Met Leu Gln Asn Ile Phe Ala Ile Phe Arg Gln Asp Ser Ser Ser Thr Gly Trp Asn Glu Thr Ile Val Glu Asn Leu Leu Ala Asn Val Tyr His Gln Ile Asn His Leu Lys Thr Val Leu Glu Glu Lys Leu Glu Lys Glu Asp Phe Thr Arg Gly Lys Leu Met Ser Ser Leu His Leu Lys Arg Tyr Tyr Gly Arg Ile Leu His Tyr Leu Lys Ala Lys Glu Tyr Ser His Cys Ala Tip Thr Ile Val Arg Val Glu Ile Leu Arg Asn Phe Tyr Phe Ile Asn Arg Leu Thr Gly Tyr Leu Arg Asn.

4. Recombinant human fibroblast β 1 interferon having the amino acid sequence:

Met Thr Asn Lys Cys Leu Leu Gln Ile Ala Leu Leu Leu Cys Phe Ser Thr Thr Ala Leu Ser Met Ser Tyr Asn Leu Leu Gly Phe Leu Gln Arg Ser Ser Asn Phe Gln Cys Gln Lys Leu Leu Trp Gln Leu Asn Gly Arg Leu Glu Tyr Cys Leu Lys Asp Arg Met Asn Phe Asp Ile Pro Glu Glu Ile Lys Gln Leu Gln Gln Phe Gln Lys Glu Asp Ala Ala Leu Thr Ile Tyr Glu Met Leu Gln Asn Ile Phe Ala Ile Phe Arg Gln Asp Ser Ser Ser Thr Gly Trp Asn Glu Thr Ile Val Glu Asn Leu Leu Ala Asn Val Tyr His Gln Ile Asn His Leu Lys Thr Val Leu Glu Glu Lys Leu Glu Lys Glu Asp Phe Thr Arg Gly Lys Leu Met Ser Ser Leu His Leu Lys Arg Tyr Tyr Gly Arg Ile Leu His Tyr Leu Lys Ala Lys Glu Tyr Ser His Cys Ala Trp Thr Ile Val Arg Val Glu Ile Leu Arg Asn Phe Tyr Phe Ile Asn Arg Leu Thr Gly Tyr Leu Arg Asn.

5. A composition comprising water and a nonglycosylated mature human fibroblast interferon polypeptide having a total of 166 amino acids and the following amino acid sequence:

X-Ser-Tyr-Asn-Leu-Leu-Gly-Phe-Leu-Gln-Arg-Ser-SerAsn-Phe-Gln-Cys-Gln-Lys-Leu-Leu-Trp-Gln-Leu-Asn-Gly-Arg-Leu-Glu-Tyr-Cys-Leu-Lys-Asp-ArgMet-Asn-Phe-Asp-Ile-Pro-Glu-Glu-Ile-Lys-Gln-Leu-Gln-Gln-Phe-Gln-Lys-Glu-Asp-Ala- Ala-Leu-Thr-Ile-Tyr-Glu-Met-Leu-Gln-Asn-Ile-Phe-Ala-Ile-Phe-ArgGln-Asp-Ser-Ser-Ser-Thr-Gly-Trp-Asn-Glu-Thr-Ile-Val-Glu-Asn-Leu-Leu-Ala-Asn-Val-Tyr-His-Gln-Ile-Asn-His-Leu-Lys-Thr-Val-Leu-Glu-Glu-Lys-Leu-Glu-Lys-Glu-Asp- Phe-Thr-Arg-Gly-Lys-Leu-Met-Ser-Ser-Leu-His-Leu-Lys-Arg-Tyr-Tyr-Gly-Arg-Ile-Leu-HisTyr-Leu-Lys-Ala-Lys-Glu-Tyr-Ser-His-Cys-Ala-Trp-Thr-Ile-Val-Arg-Val-Glu-Ile-Leu-Arg-Asn-Phe-TyrPhe-Ile-Asn-Arg-Leu-Thr-Gly-Tyr-Leu-Arg- Asn,

wherein X is Met; said composition being free of any glycosylated human fibroblast interferon.

6. The composition of claim 5 , which is free of human proteins.

7. Recombinant, mature human fibroblast interferon β 1 which is free of any glycosylated human fibroblast interferon.

8. Recombinant, human fibroblast interferon having a total of 166 amino acids and produced by expression in E. coli of an expression plasmid comprising the following DNA sequence coding for human fibroblast interferon operably linked therein for expression by an E. coli host:

ATG AGC TAC AAC TTG CTT GGA TTC CTA CAA AGA AGC AGC AAT TTT CAG

TAC TCG ATG TTG AAC GAA CCT AAG GAT GTT TCT TCG TCG TTA AAA GTC

TGT CAG AAG CTC CTG TGG CAA TTG AAT GGG AGG CTT GAA TAT TGC CTC

ACA GTC TTC GAG GAC ACC GTT AAC TTA CCC TCC GAA CTT ATA ACG GAG

AAG GAC AGG ATG AAC TTT GAC ATC CCT GAG GAG ATT AAG CAG CTG CAG

TTC CTG TCC TAC TTG AAA CTG TAG GGA CTC CTC TAA TTC GTC GAC GTC

CAG TTC CAG AAG GAG GAC GCC GCA TTG ACC ATC TAT GAG ATG CTC CAG

GTC AAG GTC TTC CTC CTG CGG CGT AAC TGG TAG ATA CTC TAC GAG GTC

AAC ATC TTT GCT ATT TTC AGA CAA GAT TCA TCT AGC ACT GGC TGG AAT

TTG TAG AAA CGA TAA AAG TCT GTT CTA AGT AGA TCG TGA CCG ACC TTA

GAG ACT ATT GTT GAG AAC CTC CTG GCT AAT GTC TAT CAT CAG ATA AAC

CTC TGA TAA CAA CTC TTG GAG GAC CGA TTA CAG ATA GTA GTC TAT TTG

CAT CTG AAG ACA GTC CTG GAA GAA AAA CTG GAG AAA GAA GAT TTC ACC

GTA GAC TTC TGT CAG GAC CTT CTT TTT GAC CTC TTT CTT CTA AAG TGG

AGG GGA AAA CTC ATG AGC AGT CTG CAC CTG AAA AGA TAT TAT GGG AGG

TCC CCT TTT GAG TAC TCG TCA GAC GTG GAC TTT TCT ATA ATA CCC TCC

ATT CTG CAT TAC CTG AAG GCC AAG GAG TAC AGT CAC TGT GCC TGG ACC

TAA GAC GTA ATG GAC TTC CGG TTC CTC ATG TCA GTG ACA CGG ACC TGG

ATA GTC AGA GTG GAA ATC CTA AGG AAC TTT TAC TTC ATT AAC AGA CTT

TAT CAG TCT CAC CTT TAG GAT TCC TTG AAA ATG AAG TAA TTG TCT GAA

ACA GGT TAC CTC CGA AAC

TGT CCA ATG GAG GCT TTG.

9. The recombinant, human fibroblast interferon of claim 8 having the amino acid sequence:

Met Ser Tyr Asn Leu Leu Gly Phe Leu Gln Arg Ser Ser Asn Phe Gln Cys Gln Lys Leu Leu Trp Gln Leu Asn Gly Arg Leu Glu Tyr Cys Leu Lys Asp Arg Met Asn Phe Asp Ile Pro Glu Glu Ile Lys Gln Leu Gln Gln Phe Gln Lys Glu Asp Ala Ala Leu Thr Ile Tyr Glu Met Leu Gln Asn Ile Phe Ala Ile Phe Arg Gln Asp Ser Ser Ser Thr Gly Trp Asn Glu Thr Ile Val Glu Asn Leu Leu Ala Asn Val Tyr His Gln Ile Asn His Leu Lys Thr Val Leu Glu Glu Lys Leu Glu Lys Glu Asp Phe Thr Arg Gly Lys Leu Met Ser Ser Leu His Leu Lys Arg Tyr Tyr Gly Arg Ile Leu His Tyr Leu Lys Ala Lys Glu Tyr Ser His Cys Ala Trp Thr Ile Val Arg Val Glu Ile Leu Arg Asn Phe Tyr Phe Ile Asn Arg Leu Thr Gly Tyr Leu Arg Asn.

10. A composition comprising water and the interferon of claim 8 .

11. The recombinant, human fibroblast interferon of claim 8 or 9 which is free of any glycosylated human fibroblast interferon.

12. A composition comprising water and the interferon of claim 11 .

13. The composition of claim 12 free of human protein.

14. A composition comprising water and the interferon of claim 9 .

Assignments (1)
RELEASE OF SECURITY INTEREST Recorded Nov 26, 2024
From: BARCLAYS BANK PLC, AS ADMINISTRATIVE AGENT
To: FTC SOLAR, INC.
Reel/Frame 069450/0947 →